Herceptin Warranty MDL To Be Considered At March 31 Hearing

(February 19, 2016, 1:36 PM EST) -- WASHINGTON, D.C. — The Judicial Panel on Multidistrict Litigation (JPMDL) on Feb. 17 said it will hear arguments at its next hearing session about the centralization of federal lawsuits against Genentech Inc. for allegedly providing 11 cancer centers with Herceptin vials that contained too little of the breast cancer drug or had the wrong instructions for the drug (In Re: Genentech Herceptin Litigation, MDL Docket No. 2700, JPML).

The JPMDL has listed the motion for its March 31 meeting.

On Feb. 5, the 11 cancer centers...
To view the full article, register now.